Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,943 | 4,693 | 541 | 12 | 52 |
| Receivables | 135 | N/A | N/A | N/A | 5 |
| TOTAL | $8,195 | $4,739 | $650 | $109 | $94 |
| Non-Current Assets | |||||
| PPE Net | 114 | 98 | 101 | 106 | 111 |
| Investments And Advances | 880 | 870 | 870 | 0 | 821 |
| Other Non-Current Assets | 77 | 77 | 75 | 821 | 0 |
| TOTAL | $1,071 | $1,045 | $1,046 | $927 | $932 |
| Total Assets | $9,266 | $5,784 | $1,696 | $1,036 | $1,026 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 709 | 630 | 651 | 1,180 | 959 |
| Other current liabilities | N/A | N/A | N/A | N/A | 315 |
| TOTAL | $1,137 | $4,250 | $4,484 | $3,379 | $3,965 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 293 | 306 | 313 | 313 | N/A |
| Other Non-Current Liabilities | 2,684 | 988 | 702 | 484 | 253 |
| TOTAL | $3,982 | $2,362 | $2,152 | $2,004 | $1,882 |
| Total Liabilities | $5,120 | $6,611 | $6,636 | $5,382 | $5,847 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,306 | 30,620 | 25,890 | 25,214 | 23,794 |
| Common Shares | 58,243 | 49,693 | 44,110 | 43,185 | 41,146 |
| Retained earnings | -54,190 | -50,615 | -49,144 | -47,625 | -46,060 |
| TOTAL | $4,147 | $-828 | $-4,940 | $-4,347 | $-4,821 |
| Total Liabilities And Equity | $9,266 | $5,784 | $1,696 | $1,036 | $1,026 |